Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples

Clinical Infectious Diseases

Volumn 50, Issue 7, 2010, Pages 1053-1059

  Hassim, Shaheen ^a   Shaw, Pamela A ^b   Sangweni, Phumelele ^a   Malan, Lizette ^a   Ntshani, Ella ^a   Mathibedi, Monkwe Jethro ^a   Stubbs, Nomso ^a   Metcalf, Julia A ^b   Eckes, Risa ^b   Masur, Henry ^b   Komati, Stephanus ^a  

^a South African National Defence Force   (South Africa)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BACTERIUM CULTURE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG SENSITIVITY; FALSE POSITIVE RESULT; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SOUTH AFRICA; SPUTUM EXAMINATION; SPUTUM SMEAR;

ADULT; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PREVALENCE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 77749330955     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651119     Document Type: Article

References (35)

1. World Health Organization (WHO). WHO report 2007. Global tuberculosis control: surveillance, planning, financing. Geneva, Switzerland: WHO, 2007.
2. Zignol M, Hosseini MS, Wright A, et al. Global incidence of multidrugresistant tuberculosis. J Infect Dis 2006; 194(4): 479-485.
3. Perkins MD, Cunningham J. Facing the crisis: improving the diagnosis of tuberculosis in the HIV era. J Infect Dis 2007; 196(suppl 1): S15-S27.
4. Iseman MD. Treatment of multidrug-resistant tuberculosis. N Engl J Med 1993; 329(11): 784-791.
5. Aziz MA, Wright A, Laszlo A, et al. Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): an updated analysis. Lancet 2006; 368(9553): 2142-2154.
6. Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006; 368(9547): 1575-1580.
7. 7. Davies GR, Pillay M, Sturm AW, Wilkinson D. Emergence of multidrug-resistant tuberculosis in a community-based directly observed treatment programme in rural South Africa. Int J Tuberc Lung Dis 1999; 3(9): 799-804. (Pubitemid 29425950)
8. Weyer K, Groenewald P, Zwarenstein M, Lombard CJ. Tuberculosis drug resistance in the Western Cape. S Afr Med J 1995; 85(6): 499-504.
9. Weyer K, Lancaster J, Bait E, Durrheim D. Tuberculosis drug resistance in Mpumalanga province, South Africa. Paper presented at: 29th World Conference of the International Union Against Tuberculosis and Lung Disease; 1998; Bangkok, Thailand.
10. Wilkinson D, Pillay M, Davies GR, Sturm AW. Resistance to antituberculosis drugs in rural South Africa: rates, patterns, risks, and transmission dynamics. Trans R Soc Trop Med Hyg 1996; 90(6): 692-695.
11. Weyer K, Lancaster J, Brand J, van der Walt M, Levin J. Survey of tuberculosis drug resistance in South Africa: 2001-2002. Pretoria, South Africa: Medical Research Council of South Africa, 2004.
12. Meintjes G, Rangaka MX, Maartens G, et al. Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance. Clin Infect Dis 2009; 48(5): 667-676.
13. Tuberculosis Strategic Plan for South Africa, 2007-2011. 20 April 2009. http://www.infb.gov.za/view/DownloadFileAction?id =72544. Accessed 19 February 2010.
14. Pepper DJ, Rebe K, Morroni C, Wilkinson RJ, Meintjes G. Clinical deterioration during antitubercular treatment at a district hospital in South Africa: the importance of drug resistance and AIDS defining illnesses. PLoS ONE 2009; 4(2): e4520.
15. Andrews JR, Shah NS, Gandhi N, Moll T, Friedland G. Multidrugresistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. J Infect Dis 2007; 196(suppl 3): S482-S490.
16. Edwards D, Vogt M, Bangani N, et al. Baseline screening for TB among patients enrolling in an ART service in South Africa. Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections; 8-11 February 2009; Montreal, Canada.
17. + cells/mm3 in South Africa. Paper presented at: 17th Conference on Retroviruses and Opportunistic Infections; 16-19 February 2010; Montreal, Canada.
18. Barbaria R, Shah S, Moll A, Gandhi N, Friedland G; Collaboration TFCaRTC. High rate of unrecognized TB and drug-resistant TB among ART clinic patients in rural South Africa. Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections; 8-11 February 2009; Montreal, Canada.
19. Basse I, Chetty S, Wang BG, J, et al. Intensive TB screening for HIVinfected patients ready to start ART in Durban, South Africa: limitations of WHO guidelines. Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections; 8-11 February 2009; Montreal, Canada.
20. Martinson N, Variava E, Chaudhary M, et al. Early mortality in a prospective cohort of hospitalized adults with a presumptive diagnosis of TB. Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections; 8-11 February 2009; Montreal, Canada.
21. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis 2003; 3(5): 288-296.
22. 22. Elliott AM, Namaambo K, Allen BW, et al. Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia. Tuber Lung Dis 1993; 74(3): 191-194. (Pubitemid 23188682)
23. Updated guidelines for the use of nucleic acid amplification tests in the diagnosis of tuberculosis. MMWR Morb Mortal Wkly Rep 2009; 58(1): 7-10.
24. Harries AD, Chilewani N, Dzinyemba W. Diagnosing tuberculosis in a resource-poor setting: the value of sputum concentrations. Trans R Soc Trop Med Hyg 1998; 92(1): 123.
25. Bruchfeld J, Aderaye G, Palme IB, Bjorvatn B, Kallenius G, Lindquist L. Sputum concentration improves diagnosis of tuberculosis in a setting with a high prevalence of HIV. Trans R Soc Trop Med Hyg 2000; 94(6) : 677-680.
26. Shea YR, Davis JL, Huang L, et al. High sensitivity and specificity of acid-fast microscopy for diagnosis of pulmonary tuberculosis in an African population with a high prevalence ofhuman immunodeficiency virus. J Clin Microbiol 2009; 47(5): 1553-1555.
27. Abdelaal A, El-Ghaffar HA, Zaghloul MH, El Mashad N, Badran E, Fathy A. Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial. Ann Clin Microbiol Antimicrob 2009; 8(4): 4.
28. 28. Greco S, Girardi E, Navarra A, Saltini C. Current evidence on diagnostic accuracy of commercially based nucleic acid amplification tests for the diagnosis of pulmonary tuberculosis. Thorax 2006; 61(9): 783-790. (Pubitemid 44369403)
29. Dinnes J, Deeks J, Kunst H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007; 11(3): 1-196.
30. Ling DI, Flores LL, Riley LW, Pai M. Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS ONE 2008; 3(2): el536.
31. Nucleic acid amplification tests for tuberculosis. MMWR. Morb Mortal Wkly Rep 1996; 45(43): 950-952.
32. Update: nucleic acid amplification tests for tuberculosis. MMWR Morb Mortal Wkly Rep 2000; 49(26): 593-594.
33. Ben Amor Y, Nemser B, Singh A, Sankin A, Schluger N. Underreported threat of multidrug-resistant tuberculosis in Africa. Emerg Infect Dis 2008; 14(9): 1345-1352.
34. Donald PR, van Helden PD. The global burden of tuberculosis-combating drug resistance in difficult times. N Engl J Med 2009; 360(23): 2393-2395.
35. Gandhi N, Shah S, Andrews J, et al. High early mortality among HIVinfected patients with extensively drug-resistant or multidrug-resistant TB in rural South Africa. Paper presented at: 16th Conference on Retroviruses and Opportunistic Infections; 8-11 February 2009; Montreal, Canada.